Orgenesis INC Form 4 insider transactions

Director Yaron Adler of Orgenesis Inc. was granted 1,750 stock options under the company's 2017 Equity Incentive Plan.

Director Adam Pelavin of Orgenesis Inc. was granted stock options under the company's 2017 Equity Incentive Plan.

Director Ashish Nanda of Orgenesis Inc. was granted 1,835 stock options under the company's 2017 Equity Incentive Plan.

Director Santhosh Nagaraj of Orgenesis Inc. was granted stock options under the company's 2017 Equity Incentive Plan.

Director Itzhak Vider of Orgenesis Inc. was granted 1,500 stock options on December 12, 2024, which vest in one year.

Director Bhalaji Jagannathan of Orgenesis Inc. was granted stock options under the company's 2017 Equity Incentive Plan.

Director Jacob Safier of Orgenesis Inc. reported multiple transactions involving common stock and the acquisition of warrants, indicating changes in his beneficial ownership.

Orgenesis Inc.'s CEO and Chairman of the Board, Vered Caplan, acquired 85,000 stock options on July 23, 2024, with vesting starting September 30, 2024.

Director Ashish Nanda reports acquisition of stock options in Orgenesis Inc.

Director Mark Goodman acquired stock options in Orgenesis Inc. on June 27, 2024.

Orgenesis Inc.'s CFO, Victor Miller, acquired 200,000 stock options on June 27, 2024, according to a recent SEC filing.

Director Itzhak Vider acquired stock options in Orgenesis Inc. on July 8, 2024.

Victor Miller, CFO of Orgenesis Inc., exercised stock options to acquire 25,000 shares of common stock on April 1, 2024.